Max Robotics — Global Service Robot Directory + US Certification

About

Adam Bohr is a leading researcher at the intersection of biomedical engineering and drug delivery, with a primary focus on developing innovative, bio-inspired technologies for gastrointestinal therapeutics. His most notable contribution is the design of cephalopod-inspired jetting devices, which mimic the propulsion mechanisms of squids and octopuses to enable needle-free, targeted drug administration within the gastrointestinal tract. This groundbreaking work, published in 2024 and already garnering 52 citations, addresses a critical challenge in biomacromolecule therapy delivery by eliminating the need for traditional needle-based injections, thereby reducing training requirements, sharps waste, and patient discomfort. Bohr’s research integrates principles from soft robotics, bioinspired design, and ingestible device engineering, advancing the field toward safer, more patient-friendly alternatives for systemic drug delivery. His work has been recognized for its translational potential, bridging fundamental biomechanics with practical medical applications. With a growing citation impact and a focus on solving real-world clinical problems, Bohr continues to push the boundaries of how we administer complex therapies, making him a key figure in the next generation of gastrointestinal drug delivery systems.